English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Background Aortic valve stenosis (AS) is a common disease. In older patients open chest valve replacement is limited due a high periprocedural risk. Therefore transaortic valve implantation (TAVI) has become a potential alternative treatment. AS causes alterations of cardiac rotation and torsion and triggers diastolic dysfunction. A poorer prognosis was observed in the presence of myocardial fibrosis (MF). Cardiac magnetic resonance imaging (CMR) can depict myocardial fibrosis by using the late gadolinium enhancement (LGE) technique. Recently T1-mapping showed promising results for the characterization of myocardial tissue. Aim of this study was to characterize the myocardium functionally and morphologically. Methods A total amount of 30 patients (16 females, age 80.6 ± 5.8 years) with severe AS were considered for TAVI. CMR was performed using a clinical 1.5T MR system (Philips Achieva). Cine imaging was performed using short and long axis orientation. Tagging of three short axis planes (apical, medial, basal) was acquired using the CSPAMM. T1 mapping of the medial short axis slice was performed prior and 10 minutes after contrast application. Quantification of global MF was assessed by using the short-axis LGE images with a threshold of ± 2 SD above a normal region defining MF. LGE images were acquired 10-15 minutes after bolus injection of 0.2 mmol/kg gadoterate meglumine.

Characterization of myocardium and myocardial motion in patients considered for transaortic valve implantation (TAVI)